Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines

Gallbladder carcinoma is the most common and aggressive malignancy of the biliary tree and highly expresses CD147, which is closely related to disease prognosis in a variety of human cancers. Doxycycline exhibited anti-tumor properties in many cancer cells. CD147 antagonist peptide-9 is a polypeptid...

Full description

Saved in:
Bibliographic Details
Main Authors: Shihang Wang, Chao Liu, Xinjiang Liu, Yanxin He, Dongfang Shen, Qiankun Luo, Yuxi Dong, Haifeng Dong, Zhigang Pang
Format: Article
Language:English
Published: SAGE Publishing 2017-10-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317718192
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850054082270593024
author Shihang Wang
Chao Liu
Xinjiang Liu
Yanxin He
Dongfang Shen
Qiankun Luo
Yuxi Dong
Haifeng Dong
Zhigang Pang
author_facet Shihang Wang
Chao Liu
Xinjiang Liu
Yanxin He
Dongfang Shen
Qiankun Luo
Yuxi Dong
Haifeng Dong
Zhigang Pang
author_sort Shihang Wang
collection DOAJ
description Gallbladder carcinoma is the most common and aggressive malignancy of the biliary tree and highly expresses CD147, which is closely related to disease prognosis in a variety of human cancers. Doxycycline exhibited anti-tumor properties in many cancer cells. CD147 antagonist peptide-9 is a polypeptide and can specifically bind to CD147. The effect of these two drugs on gallbladder cancer cells has not been studied. The aim of this study is to investigate the effect of doxycycline and antagonist peptide-9 on gallbladder carcinoma cells and the possible mechanism of inhibition on cancer cell of doxycycline. To investigate the effects of doxycycline and antagonist peptide-9 on gallbladder carcinoma cells (GBC-SD and SGC-996), cell proliferation, CD147 expression, and early-stage apoptosis rate were measured after treated with doxycycline. Matrix metalloproteinase-2 and matrix metalloproteinase-9 activities were measured after treated with different concentrations of doxycycline, antagonist peptide-9, and their combination. The results demonstrated that doxycycline inhibited cell proliferation, reduced CD147 expression level, and induced an early-stage apoptosis response in GBC-SD and SGC-996 cells. The matrix metalloproteinase-2 and matrix metalloproteinase-9 activities were inhibited by antagonist peptide-9 and doxycycline, and the inhibitory effects were enhanced by combined drugs in gallbladder carcinoma cell lines. Taken together, doxycycline showed inhibitory effects on gallbladder carcinoma cell lines and reduced the expression of CD147, and this may be the mechanism by which doxycycline inhibits cancer cells. This study provides new information and tries to implement the design of adjuvant therapy method for gallbladder carcinoma.
format Article
id doaj-art-8550a5d6d8414d229a806dba6ca41d2d
institution DOAJ
issn 1423-0380
language English
publishDate 2017-10-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-8550a5d6d8414d229a806dba6ca41d2d2025-08-20T02:52:23ZengSAGE PublishingTumor Biology1423-03802017-10-013910.1177/1010428317718192Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell linesShihang WangChao LiuXinjiang LiuYanxin HeDongfang ShenQiankun LuoYuxi DongHaifeng DongZhigang PangGallbladder carcinoma is the most common and aggressive malignancy of the biliary tree and highly expresses CD147, which is closely related to disease prognosis in a variety of human cancers. Doxycycline exhibited anti-tumor properties in many cancer cells. CD147 antagonist peptide-9 is a polypeptide and can specifically bind to CD147. The effect of these two drugs on gallbladder cancer cells has not been studied. The aim of this study is to investigate the effect of doxycycline and antagonist peptide-9 on gallbladder carcinoma cells and the possible mechanism of inhibition on cancer cell of doxycycline. To investigate the effects of doxycycline and antagonist peptide-9 on gallbladder carcinoma cells (GBC-SD and SGC-996), cell proliferation, CD147 expression, and early-stage apoptosis rate were measured after treated with doxycycline. Matrix metalloproteinase-2 and matrix metalloproteinase-9 activities were measured after treated with different concentrations of doxycycline, antagonist peptide-9, and their combination. The results demonstrated that doxycycline inhibited cell proliferation, reduced CD147 expression level, and induced an early-stage apoptosis response in GBC-SD and SGC-996 cells. The matrix metalloproteinase-2 and matrix metalloproteinase-9 activities were inhibited by antagonist peptide-9 and doxycycline, and the inhibitory effects were enhanced by combined drugs in gallbladder carcinoma cell lines. Taken together, doxycycline showed inhibitory effects on gallbladder carcinoma cell lines and reduced the expression of CD147, and this may be the mechanism by which doxycycline inhibits cancer cells. This study provides new information and tries to implement the design of adjuvant therapy method for gallbladder carcinoma.https://doi.org/10.1177/1010428317718192
spellingShingle Shihang Wang
Chao Liu
Xinjiang Liu
Yanxin He
Dongfang Shen
Qiankun Luo
Yuxi Dong
Haifeng Dong
Zhigang Pang
Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines
Tumor Biology
title Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines
title_full Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines
title_fullStr Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines
title_full_unstemmed Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines
title_short Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines
title_sort effects of matrix metalloproteinase inhibitor doxycycline and cd147 antagonist peptide 9 on gallbladder carcinoma cell lines
url https://doi.org/10.1177/1010428317718192
work_keys_str_mv AT shihangwang effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines
AT chaoliu effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines
AT xinjiangliu effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines
AT yanxinhe effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines
AT dongfangshen effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines
AT qiankunluo effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines
AT yuxidong effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines
AT haifengdong effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines
AT zhigangpang effectsofmatrixmetalloproteinaseinhibitordoxycyclineandcd147antagonistpeptide9ongallbladdercarcinomacelllines